Integrative Health Technologies, Inc. (IHTI) began operations in 1985 as Health and Medical Research, LLC., (HMR), a Clinical Research Organization (CRO) conducting pilot studies and clinical trials for products and technologies that could be integrated into pharmaceutical and non-pharmaceutical treatment plans. In July 2006 through a reverse merger, HMR incorporated as Integrative Health Technologies, Inc. (IHTI) continuing HMR’s two-fold business plan to:
The rationale for building database was and is based on increasing evidence that large research databases are not only increasingly being used for research in the 'hard' mathematics-based disciplines such as physics and engineering, but also in more 'soft' disciplines, such as sociology, psychology as well as in preventive medicine. In between the 'hard' and the 'soft' disciplines lie disciplines such as biomedicine and health care that can be subdivided into:
A number of studies have increasingly validated the value of “Big Data Analytics in HealthCare” encouraging Healthcare analysts and practitioners make inferences from valid and reliable healthcare data. One of most dramatic examples of the value of using “big data” to improve healthcare is The Framingham Heart Study. For 50 years, the Framingham Heart Study has been synonymous with the remarkable advances made in the prevention of heart disease in the United States as well as throughout the world. Fifty years of data collected from Framingham’s database has:
Framingham’s data have also provided the most important epidemiological studies in the annals of American medicine. While its contributions in the area of heart research are legion, researchers also are utilizing new data to investigate stroke, dementia, osteoporosis, arthritis, diabetes, and eye disease. Encouraged by the contributions made by analyses of Framingham’s database, IHTI dedicated significant time and resources into editing and computerizing its’ historical data into what has now become a ~35-year database of medical biomarkers.
A recent example a potential use of IHTI’s database is an announcement by the National Academies of Sciences, Engineering, and Medicine that:
"On Wednesday, September 2, from 12:00 to 5:00 pm ET The Academies will host an open online session to receive public comments on a Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine, as part of a study sponsored by the National Institutes of Health and the Centers for Disease Control and Prevention. The study will recommend priorities to inform allocation of a limited initial supply of COVID-19 vaccine, taking into account factors such as racial/ethnic and other health disparities, as well as groups at higher risk from COVID-19 due to health status, occupation, or living conditions. Input from the public, especially communities highly impacted by COVID-19, is essential to produce a final report that is objective, balanced, and inclusive."
Since virtually all of the subjects in the Database agreed to be contacted about future studies they could be contacted and asked to complete a questionnaire about their current health status. Since there will be no actual physical contact with subjects approval by an Institutional Review Board should not pose a problem nor would it place any additional burdens on the contacted subjects or the researchers.